Streetbeat News

Stock Prices

REGN

A significant investor has taken a bearish stance on Regeneron Pharmaceuticals (NASDAQ:REGN), with 70% of recent trades being bearish and 30% bullish. The trades have targeted a price range of $820.0 to $920.0 for Regeneron over the last 3 months. The current price of REGN is $818.04, with RSI indicators suggesting the stock may be approaching oversold. The next earnings are expected in 30 days.

Portfolio Pulse from Benzinga Insights

October 03, 2023 | 4:01 pm

MELI

A significant bearish stance has been taken on MercadoLibre (NASDAQ:MELI) by a large investor, as indicated by unusual options activity. The sentiment among these big-money traders is 30% bullish and 70% bearish. The whales have been targeting a price range from $700.0 to $1800.0 for MercadoLibre over the last 3 months. Currently, MELI's price is down -1.22% at $1244.01. Susquehanna has maintained their Positive rating on MercadoLibre with a price target of $1625.

Portfolio Pulse from Benzinga Insights

October 03, 2023 | 4:01 pm

GM

General Motors Co reported Q3 sales of 674,336 vehicles in the U.S., up 21% from the previous quarter. The company also saw a 28% increase in EV sales compared to Q2. At the end of the quarter, GM had 442,586 vehicles in inventory.

Portfolio Pulse from Benzinga Newsdesk

October 03, 2023 | 4:01 pm

SPGI

Seven analysts have given S&P Global (NYSE:SPGI) a somewhat bullish rating in the last quarter, with an average price target of $440.57, indicating an upside from the current price of $366.72. This average price target has increased by 3.21% from the previous average of $426.86.

Portfolio Pulse from Benzinga Insights

October 03, 2023 | 4:00 pm

SNOW

In the last quarter, Snowflake (NYSE:SNOW) received 22 analyst ratings, with the majority being bullish or somewhat bullish. The company has an average 12-month price target of $188.32, a 1.29% decrease from the previous average price target of $190.78.

Portfolio Pulse from Benzinga Insights

October 03, 2023 | 4:00 pm

BLCO

Bausch & Lomb (NYSE:BLCO) has received various analyst ratings in the last quarter, with 2 bullish, 2 somewhat bullish, and 2 indifferent. Over the past 3 months, 6 analysts have offered 12-month price targets for the company, with an average price target of $20.83, an increase of 4.15% from the previous average price target of $20.00.

Portfolio Pulse from Benzinga Insights

October 03, 2023 | 4:00 pm

DAN

Over the past 3 months, 7 analysts have published their opinion on Dana (NYSE:DAN) stock. The majority of these analysts are indifferent about the stock, with one analyst being somewhat bullish. The average price target for Dana is $18.71, which is higher than its current price of $14.36. This average price target has increased by 8.97% over the past month.

Portfolio Pulse from Benzinga Insights

October 03, 2023 | 4:00 pm

ATVI

Activision Blizzard (NASDAQ:ATVI) has outperformed the market over the past 10 years, producing an average annual return of 19.09%. If an investor had bought $100 of ATVI stock 10 years ago, it would be worth $569.14 today.

Portfolio Pulse from Benzinga Insights

October 03, 2023 | 4:00 pm

ARCH

In the last quarter, Arch Resources (NYSE:ARCH) received 4 bullish analyst ratings. The company has an average 12-month price target of $190.0, a decrease of 3.06% from the previous average price target of $196.00.

Portfolio Pulse from Benzinga Insights

October 03, 2023 | 4:00 pm

ARGX

argenx (NASDAQ:ARGX) has outperformed the market over the past 5 years by 38.13% on an annualized basis, producing an average annual return of 46.04%. If an investor had bought $100 of ARGX stock 5 years ago, it would be worth $646.49 today.

Portfolio Pulse from Benzinga Insights

October 03, 2023 | 4:00 pm